since MNK and QCOR are trading pretty much linked together now, it's VERY evident that the shares are in tighter/stronger hands(look at the rebound the past 24 hrs despite shorts' best efforts)...looks like the shorts' tactics are pretty useless.
given that Paulson can still buy almost another 10% of MNK, and that he paid as high as mid-high 70's, i think it's logical to assume that he(and other smart longs) would continue to buy MNK on any weakness. the exciting catalyst is that once the deal closes(in the next 45-60 days) and the wall street analysts(buyside) adjust their eps #s, the quant/index funds will be falling over each other chasing a large cap growing healthcare stock that's trading at near 10x p/e (and likely get take out in the future for yet another big premium).
just my 2 cents.
Agreed. Paulson will step in when and where he feels he is needed - his timing and concept may match our expectations or may be different. He might decide to let them knock don PPS at times so he can buy cheaper shares. He is smart - MNK and QCOR are shrewd companies - they have a plan, are following it, and the shorts are not gaining any shares for their trouble - and each day closer to the announcing of the vote and the close of the deal is one day less that the shorts can fight PPS.
Curious to see what other acquisition mnk has in mind end of this year as well.
Mnk should be very attractive for an bigger pharma. Wouldn't surprise me at all if they get bought out in the short or mid term for a big all cash offer.